Thetis Pharmaceuticals Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$560K
- Investors
-
9
Thetis Pharmaceuticals General Information
Description
Developer of oral therapeutics designed to treat inflammatory bowel diseases and solid tumors. The company's drug candidates target the Resolvin E1 signaling pathway to regulate immune responses, promote tissue repair, and reduce fibrosis, enabling healthcare providers to address chronic inflammation and treat patients with inflammatory bowel diseases and advanced cancers.
Contact Information
Website
www.thetispharma.comCorporate Office
- 12 Main Street
- Suite 5
- Essex, CT 06426
- United States
Corporate Office
- 12 Main Street
- Suite 5
- Essex, CT 06426
- United States
Thetis Pharmaceuticals Timeline
Thetis Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Later Stage VC | 13-Oct-2026 | $560K | Completed | Clinical Trials - Phase 1 | ||
| 15. Grant | 02-Jun-2023 | Completed | Clinical Trials - Phase 1 | |||
| 14. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 13. Later Stage VC | 11-Jul-2022 | Completed | Clinical Trials - Phase 1 | |||
| 12. Grant | 05-Apr-2022 | Completed | Clinical Trials - Phase 1 | |||
| 11. Grant | 06-Aug-2021 | Completed | Clinical Trials - Phase 1 | |||
| 10. Later Stage VC | 02-Nov-2020 | Completed | Clinical Trials - Phase 1 | |||
| 9. Later Stage VC | 31-Oct-2020 | Completed | Clinical Trials - Phase 1 | |||
| 8. Grant | 01-Mar-2020 | $1.98M | $14.2M | Completed | Clinical Trials - Phase 1 | |
| 7. Grant | 30-Nov-2019 | $2.3M | $14.2M | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Thetis Pharmaceuticals Comparisons
Industry
Financing
Details
Thetis Pharmaceuticals Competitors (4)
One of Thetis Pharmaceuticals’s 4 competitors is Immunic Therapeutics, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunic Therapeutics | Formerly VC-backed | New York, NY | ||||
| Protagonist Therapeutics | Formerly VC-backed | Newark, CA | ||||
| Athersys | Formerly VC-backed | Cleveland, OH | ||||
| Xeris Biopharma Holdings | Formerly VC-backed | Chicago, IL |
Thetis Pharmaceuticals Patents
Thetis Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240180859-A1 | Compositions and methods for immune-mediated inflammatory diseases | Inactive | 26-Oct-2022 | ||
| AU-2023228890-A1 | Cyclodextrin complexes of specialized proresolving mediators | Pending | 03-Mar-2022 | ||
| EP-4486393-A2 | Cyclodextrin complexes of specialized proresolving mediators | Pending | 03-Mar-2022 | ||
| US-12564644-B2 | Cyclodextrin complexes of specialized proresolving mediators | Active | 03-Mar-2022 | ||
| US-20240408229-A1 | Cyclodextrin complexes of specialized proresolving mediators | Active | 03-Mar-2022 | A61K47/6951 |
Thetis Pharmaceuticals Signals
Thetis Pharmaceuticals Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| The Leona M. and Harry B. Helmsley Charitable Trust | Limited Partner | |||
| Crohn's & Colitis Foundation | Limited Partner | |||
| Kenneth Rainin Foundation | Limited Partner | |||
| National Institute Of Allergy and Infectious Diseases | Government |
Thetis Pharmaceuticals FAQs
-
When was Thetis Pharmaceuticals founded?
Thetis Pharmaceuticals was founded in 2011.
-
Where is Thetis Pharmaceuticals headquartered?
Thetis Pharmaceuticals is headquartered in Essex, CT.
-
What is the size of Thetis Pharmaceuticals?
Thetis Pharmaceuticals has 7 total employees.
-
What industry is Thetis Pharmaceuticals in?
Thetis Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Thetis Pharmaceuticals a private or public company?
Thetis Pharmaceuticals is a Private company.
-
What is Thetis Pharmaceuticals’s current revenue?
The current revenue for Thetis Pharmaceuticals is .
-
How much funding has Thetis Pharmaceuticals raised over time?
Thetis Pharmaceuticals has raised $57.6M.
-
Who are Thetis Pharmaceuticals’s investors?
, The Leona M. and Harry B. Helmsley Charitable Trust, Crohn's & Colitis Foundation, Kenneth Rainin Foundation, and National Institute Of Allergy and Infectious Diseases are 5 of 9 investors who have invested in Thetis Pharmaceuticals.
-
Who are Thetis Pharmaceuticals’s competitors?
Immunic Therapeutics, Protagonist Therapeutics, Athersys, and Xeris Biopharma Holdings are competitors of Thetis Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process